S. Powar

发表

A Clinicopathologic Study of Ovarian Neoplasms in a Tertiary Hospital.

V. Pawar, Rajesh Mundhe, S. Powar, 2016 .

1239P ORCHARD osimertinib + savolitinib interim analysis: A biomarker-directed phase II platform study in patients (pts) with advanced non-small cell lung cancer (NSCLC) whose disease has progressed on first-line (1L) osimertinib

J. Riess, B. Cho, I. Okamoto, 2021, Annals of Oncology.